1. Home
  2. SCL vs RCUS Comparison

SCL vs RCUS Comparison

Compare SCL & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCL
  • RCUS
  • Stock Information
  • Founded
  • SCL 1932
  • RCUS 2015
  • Country
  • SCL United States
  • RCUS United States
  • Employees
  • SCL N/A
  • RCUS N/A
  • Industry
  • SCL Package Goods/Cosmetics
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • SCL Consumer Discretionary
  • RCUS Health Care
  • Exchange
  • SCL Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • SCL 1.1B
  • RCUS 1.2B
  • IPO Year
  • SCL N/A
  • RCUS 2018
  • Fundamental
  • Price
  • SCL $48.63
  • RCUS $11.59
  • Analyst Decision
  • SCL
  • RCUS Buy
  • Analyst Count
  • SCL 0
  • RCUS 8
  • Target Price
  • SCL N/A
  • RCUS $20.71
  • AVG Volume (30 Days)
  • SCL 192.8K
  • RCUS 728.1K
  • Earning Date
  • SCL 10-29-2025
  • RCUS 11-05-2025
  • Dividend Yield
  • SCL 3.16%
  • RCUS N/A
  • EPS Growth
  • SCL 67.06
  • RCUS N/A
  • EPS
  • SCL 2.54
  • RCUS N/A
  • Revenue
  • SCL $2,260,395,000.00
  • RCUS $262,000,000.00
  • Revenue This Year
  • SCL $9.25
  • RCUS N/A
  • Revenue Next Year
  • SCL $7.93
  • RCUS N/A
  • P/E Ratio
  • SCL $19.17
  • RCUS N/A
  • Revenue Growth
  • SCL 2.64
  • RCUS 6.07
  • 52 Week Low
  • SCL $44.23
  • RCUS $6.50
  • 52 Week High
  • SCL $82.08
  • RCUS $18.98
  • Technical
  • Relative Strength Index (RSI)
  • SCL 43.42
  • RCUS 61.75
  • Support Level
  • SCL $47.77
  • RCUS $11.04
  • Resistance Level
  • SCL $49.56
  • RCUS $12.05
  • Average True Range (ATR)
  • SCL 1.34
  • RCUS 0.56
  • MACD
  • SCL 0.03
  • RCUS 0.01
  • Stochastic Oscillator
  • SCL 20.19
  • RCUS 70.05

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: